Current Editions
Rare disease spotlight: Friedreich ataxia moves beyond mitochondrial bandages
After Skyclarys, FA R&D shifts from antioxidant small molecules to FXN-restoring gene therapies and fusion proteins
Product Development
Emerging Company Profile
Kenai: Off-the-shelf Parkinson’s progenitors with precision transplant tech
Allogeneic cell therapy newco brings precision brain delivery, functional imaging and ambitions beyond motor symptom control
Finance
Strong demand allows Xenon, Dianthus to upsize follow-ons: Finance Report
Plus: CRISPR, Indivior offerings; Relmada’s PIPE, Breakout Ventures’ new fund, and more
BioCentury ISSN 1097-7201